Bapineuzumab for mild to moderate Alzheimer's disease: a meta-analysis of randomized controlled trials.
about
Fine-tuning PERK signaling for neuroprotection.A Toxic Conformer of Aβ42 with a Turn at 22-23 is a Novel Therapeutic Target for Alzheimer's DiseasePerspective Insights into Disease Progression, Diagnostics, and Therapeutic Approaches in Alzheimer's Disease: A Judicious Update.Efficacy and safety of anti-amyloid-β immunotherapy for Alzheimer's disease: a systematic review and network meta-analysis.Cerebral Hypoperfusion and Other Shared Brain Pathologies in Ischemic Stroke and Alzheimer's Disease.Review: Neuropathology and behavioural features of transgenic murine models of Alzheimer's disease.Whole transcriptome profiling of Late-Onset Alzheimer's Disease patients provides insights into the molecular changes involved in the disease.
P2860
Q39393398-7AA748B8-B57B-4597-9E39-2C71FE758347Q41717716-09483135-73BD-4257-8376-61E9A14FA286Q47107778-2E316CBA-84FF-40F4-8C69-5398FD882BE6Q47138749-5350E09A-A091-46EF-AFB3-DBA09592661AQ47711014-6EA3CC6D-62EE-49F4-A0F6-3AD71C6739B3Q48113034-1BD6CA85-4519-485D-BC89-D7298AA61DE0Q50531480-0505FD31-B9A1-4F1D-8FB9-F66C3F8B0F18
P2860
Bapineuzumab for mild to moderate Alzheimer's disease: a meta-analysis of randomized controlled trials.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Bapineuzumab for mild to moder ...... randomized controlled trials.
@ast
Bapineuzumab for mild to moder ...... randomized controlled trials.
@en
type
label
Bapineuzumab for mild to moder ...... randomized controlled trials.
@ast
Bapineuzumab for mild to moder ...... randomized controlled trials.
@en
prefLabel
Bapineuzumab for mild to moder ...... randomized controlled trials.
@ast
Bapineuzumab for mild to moder ...... randomized controlled trials.
@en
P2093
P2860
P1433
P1476
Bapineuzumab for mild to moder ...... randomized controlled trials.
@en
P2093
Ammar M AlSafadi
Amro Aglan
Rana Fouda
Reham Salama
Samar Fouda
P2860
P2888
P356
10.1186/S12883-017-0850-1
P577
2017-04-04T00:00:00Z
P6179
1084512801